Trevena (TRVN) Files $86.25M IPO

October 9, 2013 3:42 PM EDT
Trevena, Inc. (Nasdaq: TRVN) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering price is $86.25 million. The company plans to list on the Nasdaq Global Market under the ticker, TRVN.

The offering is being made via Barclays, Jefferies, Canaccord Genuity, JMP Securities, and Needham & Company.

Trevena a clinical stage biopharmaceutical company that discovers, develops and intends to commercialize therapeutics that use a novel approach to target G protein coupled receptors, or GPCRs.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Insiders' Blog

Related Entities

Jefferies & Co, Needham & Company, JMP Securities, Barclays, Canaccord Genuity, IPO